HIV

Adolescents and young adults aged 13 to 24 years old are particularly vulnerable to HIV infection, representing 21% of newly infected individuals in most recent data.

Prolonged delay in antiretroviral treatment among patients necessitate scrutinization of the current guidelines for HIV therapy.

Prior studies suggest that as many as two-thirds of all older HIV-positive Americans have experienced stigma due to the disease and their age.

Stigma partially drives poorer health outcomes in patients with HIV.

Funding will be spread throughout several mentorship programs for youths with HIV to help navigate adult care.

According to new findings, home-based HIV testing kits could be an effective strategy to reach individuals who have never been tested.

The investigators hope the study leads to earlier HIV testing and related prenatal care.

Investigators seek to limit mother-to-child transmission of HIV without harming the immune development of infants.

Many individuals at-risk of contracting HIV do not test routinely or have never been tested.

Four doses of PrEP around the time of sexual activity reduced HIV-infection risk by 97%.

Researchers have found a new antibiotic that may have the potential to treat gonorrhea, according to a study published recently in Antimicrobial Agents and Chemotherapy.

Housing Opportunities for Persons With AIDS program awarded $320.4 million to qualifying states and local jurisdictions.

Partner violence negatively impacts the ability of women with HIV to adhere to antiretrovirals.

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions, discusses the importance of specialty pharmacists in a patient-centric environment.

Mosaic vaccines observed to bolster immune response against HIV.

The study is the first to evaluate VRC01 antibody in patients who started antiretroviral therapy during acute HIV infection.

Pharmacist intervention on drug-related problems in HIV outpatients can alleviate adherence issues.

Top news of the week from Specialty Pharmacy Times.

Pilot project to bring pre-exposure prophylaxis to the Philippines for the first time.

A look at last week's top stories in the world of pharmacy.

HIV-positive patients may not remain adherent to antiretroviral therapy and feminizing hormone therapy due to concerns over drug interactions.

Research advances hunt for a safe and effective preventative HIV vaccine.

HIV continues to be a global problem, and researchers from Brazil have joined the growing chorus of voices in emphasizing that pharmacist involvement in care for patients with HIV improves outcomes.

Scientists say ring containing pre-exposure prophylaxis and Truvada is safe in US teens, now need data in African adolescent girls.

New cases of HIV in Swaizland down 50% between 2011 and 2016.